Dehydroquinate synthase (DHQS) is the second enzyme in the prechorismate (shikimate) pathway and is a potential target for tuberculosis drugs. The enzyme requires zinc or similar metals for activity. In Aspergillus nidulans DHQS is theN-terminal enzyme of the pentafunctional AROM complex.
The active site of the enzyme D-xylose isomerase contains two divalent metal ions, usually Mg2+, Mn2+, or Co2+.1.2 \Ve have investigated the structure and characteristics of the metal-free enzyme and the enzyme containing the normally encountered metal ions (Mg2+, Mn2+, Co2+), as well as the effects on the structure of adding divalent cations such as Ni2+, Zn2+, Pb2+, and Ca2+. The variation in enzyme activity as a function of added metal ion, and the changes that these metal ions cause in the geometry of the active site of the enzyme will be desc1ibed. X-ray structural studies have all been carTied out at 1.9-1.6 A resolution. A detailed desc1iption of different metal ion environments will be provided. The extent of competition between metal ions for the two sites is revealed by this type of study. The results of our analysis of metal binding will be compar·ed with results from previous NMR studies on some of these systems)
Supported by grant CA-10925 from National Institutes of Health. Stromelysin, a zinc-dependent proteinase, is a member of the matrix metalloproteinases (MMP). MMPs ar·e believed to play an important role in pathological conditions such as osteoarthritis, rheumatoid ar·thritis and tumor invasion. The crystal structures of native truncated stromelysin (the catalytic domain) and its inhibitor-bound complexes have been solved. The native structure has been refined to 2.0 A resolution (R-factor 0.21, R-free 0.29). The complexes were formed both from diffusi~n soaking and cocrystallization, and have been refined to 2.3 A resolution (R-factor and R-free 0.19 and 0.31 for the soaked crystals; 0.19 and 0.33 for the co-crystals, respectively). The native and the inhibitorsoaked crystals are in space group P212121. with two molecules (A and B) in the asymmetric unit, associating as a dimer. The inhibitor-bound co-crystals, also existing as a dimer, ar-e in space group C2, one molecule per asymmetric unit. There ar·e three ahelices and one twisted, five-strand ~-sheet in each molecule with one catalytic Zn2+, one structural Zn2+ and three Ca2+ ions. The catalytic zinc is ligated to three histidines (H201, H205 and H211), with distances ar-ound 2.1-2.2 A. The fourth and possibly the fifth ligands may come from substrate, inhibitor, another stromelysin molecule or solvent
The inhibitor binding obtained by soaldng or co-crystallization is basically identicaL The Pl' portion of the inhibitor binds to a highly hydrophobic pocket Most residues between the native and the inhibitor-bound complex stmctures match very well except the inhibitor-binding loop (residues 222-231). The major difference occurs at Y223. In native structure, the side chain ofY223 occupies the position that is occupied by the P 1' portion of an inhibitor in the complex. The inhibitor has to push away the Y223 in order to fit into the binding site. Moreover, the inhibitor binding and Y223 movement induce movement of the entire loop. This makes the loop completely different in the native and in the complex. Some residues (Ca) differ by as much as 5 A. In native stromelysin, a symmetry-related molecule B has its C-tenninal (251-255) interacting with the active site of molecule A of the central unit. The last residue, T255, has its car-boxylate group ligated to the catalytic zinc, fanning two ligand bonds, in a si1nilar-manner as an inhibitor. This symmetrical C-tenninal-active site interaction occurs for one molecule only. In molecule A, the last four Cteiminal residues ar·e disordered as a flexible taiL The situation in the inhibitor-bound complexes is more complicated. In molecule B, only the inhibitor binds to the active site. But in molecule A, inhibitor competes with the C-tenninal of a symmetry-related molecule B.
